The loss of Gilead Sciences under GAAP for 9 months of 2020 was $1.455 billion, against a profit of $2.675 billion in the previous year. Revenues increased by 4.2% to $17.268 billion against $16.57 billion a year earlier.
The loss of Gilead Sciences under GAAP for 9 months of 2020 was $1.455 billion, against a profit of $2.675 billion in the previous year. Revenues increased by 4.2% to $17.268 billion against $16.57 billion a year earlier. 
investors.gilead.com
English (US) 